cinnamon

all catalysts(1)

News(7)

• Opinion: How to disrupt the health misinformation business model
  One way to fight medical misinformation: make it easier for people to understand when they are being manipulated, write Paul Martin Jensen and Avi Tuschman.
  stat · 7d ago
• STAT+: Pharmalittle: We’re reading about Chinese trial sites being probed, RFK Jr. and peptides, and more
  U.S. lawmakers are investigating whether several large drugmakers have been involved ​in clinical trials in China that helped fuel its military capability
  stat · 1mo ago
• STAT+: Pharmalittle: We’re reading about U.S. pressure on European drug prices, longer shortages, and more
  A new analysis found the average drug shortage in 2025 had lasted 5.3 years, exceeding the 4.3 years seen in 2024
  stat · 2mo ago
• STAT+: Pharmalittle: We’re reading about GLP-1 drugs and knees, FDA cell and gene therapy guidance, and more
  Taking weight loss drugs for at least three years could prevent thousands of knee replacements a year, a new study found
  stat · 2mo ago
• STAT+: Pharmalittle: We’re reading about pharma lobbying, Bristol’s deal with a Chinese partner, and more
  The 17 pharmaceutical companies anchoring TrumpRx poured more than $130 million into federal lobbying in 2025 — a nearly 23% surge
  stat · 3mo ago
• Why the FDA is authorizing fruit-flavored vapes
  Marty Makary says he was "skeptical initially" about flavored vapes but that age-gating technology could limit their use.
  stat · 3mo ago
• STAT+: Pharmalittle: We’re reading about RFK Jr. targeting antidepressants, J&J pushing an IBD drug, and more
  HHS Secretary Robert F. Kennedy Jr. announced initiatives to rein in prescribing of SSRIs, the most widely used antidepressants
  stat · 3mo ago